Yoan Velut
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).
Journal: Immuno-oncology technology
Published: January 08, 2026
Phase I(b) study evaluating the safety and efficacy of intratumoral agonistic anti-CD40 (selicrelumab) in combination with anti-PD-L1 (atezolizumab) in patients with refractory or relapsed B-cell lymphoma (ITSELF trial).
Journal: Immuno-oncology technology
Published: January 08, 2026
Epigenetic signatures on plasma cell-free DNA to detect kidney allograft rejection in a non-invasive way: development of a 10-plex digital PCR assay.
Journal: Biomarker research
Published: June 25, 2025
Molecular profiling and risk stratification in solitary bone plasmacytoma.
Journal: Leukemia
Published: March 02, 2025
The tumor immune microenvironment of SCLC is not associated with its molecular subtypes.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 15, 2024
Antagonistic actions of PAK1 and NF2/Merlin drive myelin membrane expansion in oligodendrocytes.
Journal: Glia
Published: January 07, 2024
SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 01, 2022
Co-culture of exogenous oligodendrocytes with unmyelinated cerebella: Revisiting ex vivo models and new tools to study myelination.
Journal: Glia
Published: January 26, 2021
Chemoradiotherapy efficacy is predicted by intra-tumour CD8+/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 31, 2020
Biomarkers predictive of PD1/PD-L1 immunotherapy in non-small cell lung cancer
Journal: Revue de pneumologie clinique
Published: October 20, 2018
Proposal for a Combined Histomolecular Algorithm to Distinguish Multiple Primary Adenocarcinomas from Intrapulmonary Metastasis in Patients with Multiple Lung Tumors.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 11, 2018
Analysis of immune microenvironment by multiplex immunohistochemistry in locally advanced non-small cell lung cancer: Principles and perspectives
Journal: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Published: June 06, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026